CUSIP: 29668H104
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,873,579
-
Share change
-
-1,095,481
-
Total reported value
-
$5,241,000
-
Price per share
-
$0.55
-
Number of holders
-
10
-
Value change
-
-$603,758
-
Number of buys
-
3
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 29668H104:
Institutional Holders of ESSA PHARMA INC - COM as of Q2 2017
As of 30 Jun 2017,
ESSA PHARMA INC - COM was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,873,579 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, Clarus Ventures, LLC, Omega Fund Management, LLC, AWM Investment Company, Inc., DEERFIELD MANAGEMENT CO, ACUTA CAPITAL PARTNERS, LLC, CITADEL ADVISORS LLC, ROYAL BANK OF CANADA, UBS Group AG, and BANK OF MONTREAL /CAN/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.